Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Accounts Payables (2017 - 2025)

Historic Accounts Payables for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $337595.0.

  • Regenerative Medical Technology's Accounts Payables fell 6939.03% to $337595.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $337595.0, marking a year-over-year decrease of 6939.03%. This contributed to the annual value of $563703.0 for FY2024, which is 3379.01% up from last year.
  • According to the latest figures from Q3 2025, Regenerative Medical Technology's Accounts Payables is $337595.0, which was down 6939.03% from $179538.0 recorded in Q2 2025.
  • Regenerative Medical Technology's Accounts Payables' 5-year high stood at $1.1 million during Q3 2024, with a 5-year trough of $81808.0 in Q2 2021.
  • Its 5-year average for Accounts Payables is $388604.8, with a median of $363808.0 in 2021.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 7916.4% in 2021, then surged by 20043.01% in 2024.
  • Regenerative Medical Technology's Accounts Payables (Quarter) stood at $181442.0 in 2021, then surged by 35.28% to $245463.0 in 2022, then skyrocketed by 71.65% to $421334.0 in 2023, then soared by 33.79% to $563703.0 in 2024, then crashed by 40.11% to $337595.0 in 2025.
  • Its Accounts Payables was $337595.0 in Q3 2025, compared to $179538.0 in Q2 2025 and $598001.0 in Q1 2025.